Organ and tumor dosimetry of Lu-177-DOTA-Tyr(3)-octreotate (Lu-TATE) and Y-90-DOTA-Tyr(3)-octreotide (Y-TOC): A preliminary study in 2 patients.

Kooij, P; Pauwels, Stanislas; Kwekkeboom, D; Walrand, Stephan; Konijnenberg, M; Barone, Raffaella; Smith, C; Krenning, E.

Organ and tumor dosimetry of Lu-177-DOTA-Tyr(3)-octreotate (Lu-TATE) and Y-90-DOTA-Tyr(3)-octreotide (Y-TOC): A preliminary study in 2 patients.

Kooij, P

;

Pauwels, Stanislas

;

Kwekkeboom, D

;

Walrand, Stephan

;

Krenning, E.

;et.al.

(2002)

Files

No attached file found for this publication.

Details

Authors

Kooij, P
Author
Pauwels, StanislasUCLouvain
Author
Kwekkeboom, D
Author
Walrand, StephanUCLouvain
Author
Barone, RaffaellaUCLouvain
Author
Krenning, E.
Author

Affiliations

UCLouvainCliniques universitaires Saint-Luc
UCLouvainMD/MINT - Département de médecine interne

Citations

APA
Chicago
FWB

Kooij, P., Pauwels, S., Kwekkeboom, D., Walrand, S., Konijnenberg, M., Barone, R., Smith, C., & Krenning, E. (2002). Organ and tumor dosimetry of Lu-177-DOTA-Tyr(3)-octreotate (Lu-TATE) and Y-90-DOTA-Tyr(3)-octreotide (Y-TOC): A preliminary study in 2 patients. The Journal of Nuclear Medicine, 43(5), 316P-316P. (Original work published 2002)